Phimed Europe

1 known investors

Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.